2018 Massachusetts Life Sciences Innovation Day Agenda

Tentative Agenda 



                   Foyer Harvard Hall

8:00 AM

Registration & Breakfast

                          Harvard Hall

8:50 AM

Welcome by Conference Chair Abigail Barrow, Director, Massachusetts Technology Transfer Center

9:00 AM

Intro by Carla Reimold, Director of Industry Programs, MLSC

Opening Keynote by Marvelle Sullivan Berchtold, Managing Director, J.P. Morgan Chase


 Plenary Panel: Recently Funded Startups

Colin Carpenter, CEO &Co-founder, Siris Medical
Joyce A. Lonergan, CEO & co-founder, Mellitus, LLC
Gitte Pedersen, Founder, Genomic Expression
Leila Pirhaji, ReviveMed, Founder & CEO

Moderator: Thomas Engellenner, Partner, Pepper Hamilton

“An Analysis of Recent Fundraising and Investment Trends” by Clark Hayes, Managing Director, Head of Northeast Life Science and Healthcare Business Development

                             Foyer Harvard Hall and President’s Room



                  Massachusetts Room

Aesculapian Room

11:00 AM

Panel: Getting and leveraging funding

Eric Evans, Executive Chairman, Pykus Therapeutics
Martin Heidecker, Boehringer Ingelheim, Managing Director, Venture Fund USA Inc.
David Raiser, Co-Founder & CEO, Aldatu Biosciences
Stacie Weninger, President, F-Prime Biomedical Research Initiative

Moderator: Al Sokol, Partner, McDermott Will & Emery LLP

Panel: 3 start-up companies pitch

Christopher Locher, CEO &Co-Founder, Versatope Therapeutics, Inc.
Lindsay Lozeau, Co-founder & CTO, AMProtection
Ida Pavlichenko, Co-Founder, PionEar

Rakhshita Dhar
Business Development, Roche Partnering
Aaron Schwartz, Director, Search & Evaluation Global Drug Discovery, Novo Nordisk
Avi Spier, Director, Search and Evaluation, Novartis Institutes of Biomedical Research

Moderator:  Shawn Foley, Burns & Levinson, LLP

Harvard Hall

12:15 PM

Intro by Bob Coughlin, President & CEO, MassBio

Lunch Keynote by Mark Namchuk, SVP of Research, Non-Clinical and Pharmaceutical Development,  Alkermes

An Analysis of Recent Exits in the Life Sciences” by Valerie Dixon, Executive Director, J.P. Morgan’s Healthcare Investment Banking

                  Massachusetts Room

               Aesculapian Room

1:45 PM

Panel: Getting to proof of concept

Stacy Chin, CEO & Co-founder, Hydroglydecoatings
Barbara Fox, CEO, Tilos Therapeutics, Inc.
Jonathan Larson, Founder & CEO,  Lariat Biosciences, Inc.
David Tabatadze, Co-Founder & President, ZATA Pharmaceuticals

Moderator: Jim Jersey, Executive Director, CRL

Panel:  Gene Therapy - the Road Ahead

Jim Burns, President & CEO, Casebia
Michael Kelly, Director, ADPM Gene Therapy, Biogen
Tina Liu, Entrepreneur-in-Residence, Wyss Institute at Harvard University
Stephen Potter, CBO, AGTC

Moderator: Richard Snyder, CSO, Brammer Bio

                           Foyer Harvard Hall and President’s Room



                      Massachusetts Room

               Aesculapian Room


Panel: Life after Death - What happens when your science or technology or funding or regulatory plans don’t proceed as expected

Irene Abrams, Vice President, Technology Development and New Ventures, Boston Children’s Hospital
Jeff Behrens, President & CEO, Siamab Therapeutics, Inc.
Samir Sabir, President & Director, Momelan Technologies
Bill Skillman, President & CEO, Velico Medical

Moderator: Rachel Meyers, Entrepreneur-In-Residence, Third Rock Ventures

Panel: The Impact of AI and Big Data Analytics in Healthcare

Jamie Band, Analyst, Tiger Management
Eleanor Howe, Founder, Diamond Age Data Science, Inc.
Zak Kohane, Chair of the Department of Biomedical Informatics, Harvard Medical School

Moderator: Luba Greenwood, Strategic Business Development & Corporate Ventures, Verily, an Alphabet company

                   Harvard Hall

5:00 PM

Reception / Innovators’ Marketplace/Poster Awards